Coriell Cell产品代理

产品分类 > 科研试剂 > Coriell Cell产品代理

Coriell Cell产品代理

科里尔医学研究所——原名南泽西医学研究基金会,后称为医学研究所——由著名病毒学家刘易斯·科里尔博士于 1953 年创立。科里尔博士是科学先驱,为通过无菌细胞培养技术和细胞系冷冻保存的进步进行生物医学研究。
在培养物中维持活的人类细胞并防止它们受到污染的能力导致了脊髓灰质炎研究的一个关键突破:它使科学家能够培育脊髓灰质炎病毒并致力于开发第一种疫苗。但也许科里尔博士最经久不衰的遗产是他对知识的慷慨,以及他将科学家聚集在一起探索研究问题和合作解决方案的能力。
今天,Coriell 的使命是通过生产世界一流的生物材料并在生物样本库、个性化医疗和干细胞生物学方面进行开创性研究,加速科学发现。
我们在多个方面致力于了解人类遗传疾病。 Coriell Personalized Medicine Collaborative® (CPMC®) 研究旨在了解遗传信息在临床护理中的有用性。我们还通过在诱导多能干细胞 (iPSC) 研究中发挥重要作用,巩固我们在细胞生物学领域的历史。 Coriell 的生物库管理着世界上最多样化的细胞系、DNA 和其他生物材料,这些材料收集和分发给国际生物医学研究界使用。事实上,在 1960 年,Coriell 是美国国立卫生研究院认可的首批两个官方细胞库之一。
价格: 0.00

The Coriell   Institute for Medical Research – originally known as South Jersey Medical Research Foundation and   then as the Institute for Medical Research– was founded by famed virologist Dr. Lewis L. Coriell in 1953. Dr.   Coriell was a scientific pioneer, making invaluable contributions to   biomedical research through advances in aseptic cell culture techniques and   cryopreservation of cell lines.

   

The ability to sustain living human cells in culture – and keep

them from   being contaminated – led to a key breakthrough in polio research: it enabled   scientists to grow the polio virus and work toward the first vaccine. But   perhaps Dr. Coriell’s most enduring legacy was his generosity in knowledge and his   ability to bring scientists together to explore research questions and   collaborate on solutions.

Today,   Coriell's mission is to accelerate scientific discovery by generating   world-class biomaterials and conducting groundbreaking research in   biobanking, personalized medicine and stem cell biology.

   

Our mission to understand human genetic disease is being pursued on several fronts. The Coriell Personalized Medicine Collaborative® (CPMC®) research study is seeking to understand the usefulness of genetic information in clinical care. We are also building upon our history in cell biology by playing an important role in induced pluripotent stem cell (iPSC) research. And Coriell’s biobank manages the world’s most diverse collection of cell lines, DNA, and other biomaterials gathered and distributed for use by the international biomedical research community. In fact, in 1960 Coriell was one of the first two official cell banks recognized by the National Institute of Health.